Demant

At Demant we create life-changing differences through hearing health.

Demant is a world-leading hearing healthcare group built on a heritage of care, health and innovation since 1904. The Group offers solutions and services to help people connect and communicate with the world around them. For more than a century, the Demant Group has played a vital part in developing innovative technologies and gathering know-how to help improve people’s hearing and health. In ever

y aspect, from providing hearing care to delivering hearing aids and diagnostic equipment and services to hearing care professionals and users all over the world, Demant is active and engaged. The Demant Group operates in a global market with subsidiaries in more than 30 countries, employs more than 26,000 employees and generates annual revenue of more than DKK 22 billion. Our products are sold in more than 130 countries where we create life-changing differences through hearing health. Listed on Nasdaq Copenhagen stock exchange as a blue chip stock, Demant is the parent company behind world-renowned and commercially successful brands as Oticon, Bernafon, Sonic, Philips Hearing Solutions, Audika, MAICO, Interacoustics, Amplivox, Grason-Stadler, MedRx and Audioscan. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks. If you want to know how we process your personal data on social media platforms, visit this site: https://www.demant.com/privacy-notice

08/06/2026

[Heritage Highlights] From one shop in Odense to more than 4,500 hearing care clinics worldwide

Exactly 122 years ago today, on 8 June 1904, Hans Demant formalised an agreement to distribute hearing aids in Denmark, the start of a journey that would grow far beyond its origins.

At 57 Kongensgade in Odense, the Demant family lived upstairs while everyday business took place below. Bicycles and sewing machines filled the shop, and it was here that hearing aids would soon become part of the offering.

Driven by a desire to help his hearing‑impaired wife, Hans Demant brought home a hearing aid from England. What began as a personal act of care soon became something more: from this very shop, he started introducing hearing aids to people in Denmark – setting in motion a company dedicated to making life-changing differences to people living with hearing loss.

[This post is part of 𝘏𝘦𝘳𝘪𝘵𝘢𝘨𝘦 𝘏𝘪𝘨𝘩𝘭𝘪𝘨𝘩𝘵𝘴: short glimpses into the stories and materials preserved in our archives].

05/05/2026

Tuesday, Demant released its Interim Management Statement for Q1 2026.
Our CEO, Søren Nielsen, shares his perspective on the quarter and the moving parts behind Demant’s strong start to the year, with the Group delivering 6% organic revenue growth.

He also reflects on the positive impact of our newest flagship hearing aids Oticon Zeal and on the contribution from all three business areas to the quarter. He also outlines how Demant is positioned as we move through the coming months of 2026.

07/04/2026

Today we celebrate and join this year’s theme, “Together for health. Stand with science”, recognising the power of scientific collaboration to improve global health. As an essential part of healthcare, hearing health is also driven by this scientific approach – helping people to connect, participate and belong.

Advancing hearing health requires innovation and research, cross‑disciplinary collaboration, and a commitment to transforming evidence into life-changing differences for people living with hearing loss. And this is exactly what we bring together in our research centres to shape the future of hearing healthcare.

- Eriksholm Research Centre, the world’s leading applied hearing research facility, explores personalised audiology, cognitive hearing science, intent decoding and AI - to better understand real-life hearing needs.
- Interacoustics A/S Research Unit (IRU), based at Danmarks Tekniske Universitet - DTU, translates research into practical solutions for hearing care professionals through applied and clinical work in audiometry, electrophysiology, hearing aid fitting, and impedance.

We are proud to stand with the researchers, clinicians and collaborators who contribute to shaping a better future in hearing healthcare.

19/03/2026

[Heritage Highlights] From care to purpose

In 1902, the Demant family posed for a formal photograph - unaware that only two years later, hearing aids would become a defining part of their story and the beginning of .

At the time, Camilla Louise lived with hearing difficulties. Wanting to support her, her husband Hans Jørgen Demant travelled to London to bring home a new electric hearing aid. The change it brought to Camilla’s life spread quickly, and soon others approached him for the same help.

On 8 June 1904, he became the sole agent for General Acoustic in Denmark. This marked the start of a journey that still shapes our purpose today: improving life for people with hearing difficulties.

[This post is part of Heritage Highlights: short glimpses into the stories and materials preserved in our archives].

12/03/2026

We were pleased to welcome our shareholders to Demant’s headquarters in Smørum for our Annual General Meeting. As per tradition, the meeting is an opportunity to present the Group's development in the year that passed, including key strategic milestones such as the acquisition of KIND and the launch of hashtag .

This time, the AGM also marked an important transition for Demant’s Board of Directors. We said goodbye to Niels B. Christiansen after 18 years of dedicated service on Demant’s Board, the last nine as Chair. We are deeply grateful for his leadership and service throughout his tenure.

In his final address to Demant shareholders, Niels highlighted: “For almost two decades, I have had the pleasure of following Demant’s development closely – a journey marked by significant growth and value creation, continuous innovation and an unwavering focus on improving the lives of people with hearing loss."

Following the AGM, the Board appointed Kristian Villumsen as the new Chair. Kristian, who has been a member of Demant’s Board since 2021, brings deep insights into the healthcare industry and extensive international leadership experience from executive management and board positions.

The general assembly also elected Thomas Hofman-Bang as a new member of the Board of Directors. Thomas adds international leadership experience and a strong background in accounting and manufacturing companies. Welcome on board, Thomas!

Thank you to all shareholders for putting your trust in Demant.

03/02/2026

Today, we released our 2025 Annual Report, presenting our financial performance and sustainability progress for the past year.

▪️Key financial figures: We delivered 5% of revenue growth in local currencies, predominantly driven by good performance in our Hearing Care business area. Strategic acquisitions such as the German retailer KIND contributed meaningfully to this development.

▪️Our core impact: Demant improved over 12 million lives through innovative solutions in 2025. We also carried out 1.6 million hearing tests in our clinics, strongly contributing to raise awareness of hearing healthcare.

▪️ Innovation in focus: The launch of Oticon Zeal. The world's most discreet, complete in-ear hearing aid, marked an important milestone for the industry, setting a new standard for technology and user experience.

▪️ Climate impact: Demant reduced its scope 1 and 2 market-based GHG emissions by 9% and we met our 2025 target of sourcing 50% of the Group’s energy consumption from renewable sources.

▪️Diversity: The share of women in top‑level management increased to 33%, reflecting good progress towards our 2030 target of 35%.

👉 Explore Demant’s full 2025 financial and sustainability results in the comments.

23/12/2025

Different languages, different traditions, different teams, and different markets - all connected by one shared wish to spread joy this festive season and one shared purpose that unites us, creating life-changing differences through hearing health.

From all of us at Demant: Happy Holidays and a joyful New Year!

03/12/2025

We are thrilled to officially welcome 3,000 new colleagues to Demant and additional 650 clinics to our +4,000 clinic network, following the completion of Demant’s largest-ever acquisition: KIND.

This strategic move will allow us to help more people hear better through personalised care and innovative solutions.

Together, we will continue shaping the future of hearing healthcare.

05/11/2025

Tuesday evening, Demant published its Interim Management Statement for Q3 2025.

This quarter’s highlights include:

· The Group delivers organic growth of 3% driven by solid performance in Hearing Care
· The hearing aid market remained softer than normal with sequential slowdown in US commercial market
· Outlook for 2025: Organic growth of 1-3% and EBIT of DKK 3,900-4,300 million

Browse through our key data below.

05/11/2025

Demant released its Interim Management Statement for Q3 2025

In this video, our CEO Søren Nielsen shares his reflections on Demant’s performance in the third quarter. Among others, he highlights the Group’s 3% organic revenue growth, driven by strong results in the Hearing Care business area, and offers insights into how global macroeconomic uncertainties are impacting the hearing aid market.

Read the full statement here: https://www.demant.com/investor-relations/company-announcements #/embedded/announcement/14655735?publisherId=13560112&widget=true

Adresse

Kongebakken 9
Smørumnedre
2765

Telefon

+4539177300

Internet side

http://www.demant.com/

Underretninger

Vær den første til at vide, og lad os sende dig en email, når Demant sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Kontakt Virksomheden

Send en besked til Demant:

Genveje

Vil du plassere din virksomhed på toppen av Sundhed Og Skønhed Virksomhed-listen i Smørumnedre?

Del

Type

Medicin og sundhed